![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Safety and Efficacy of Vesatolimod (GS-9620) in Patients With
Chronic Hepatitis B Who Are Not Currently on Antiviral Treatment
|
|
|
Reported by Jules Levin
AASLD: The Liver Meeting® 2017, October 20-24, 2017, Washington, DC
Kosh Agarwal,1 Sang Hoon Ahn,2 Magdy Elkhashab,3 Kyungpil Kim,4 Audrey H. Lau,4 Anuj Gaggar,4 G. Mani Subramanian,4
John G. McHutchison,4 Pietro Andreone,5 Hyung Joon Kim,6 Wan-Long Chuang,7 Mindie H. Nguyen8
1Institute of Liver Studies, King's College Hospital, London, UK; 2Severance Hospital, Yonsei University Health System, Seoul, South Korea; 3Toronto Liver Centre, Toronto, Ontario, Canada; 4Gilead Sciences, Inc., Foster City, CA;
5Azienda Ospedaliero-Universitaria di Bologna, Italy; 6Chung-Ang University Hospital, Seoul; 7Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan; 8Stanford University, Palo Alto, CA
![1108171](../images/110817/110817-12/1108171.gif)
![1108172](../images/110817/110817-12/1108172.gif)
![1108173](../images/110817/110817-12/1108173.gif)
![1108174](../images/110817/110817-12/1108174.gif)
![1108175](../images/110817/110817-12/1108175.gif)
![1108176](../images/110817/110817-12/1108176.gif)
![1108177](../images/110817/110817-12/1108177.gif)
![1108178](../images/110817/110817-12/1108178.gif)
![1108179](../images/110817/110817-12/1108179.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|